Probably Genetic

The business model of Probably Genetic revolves around offering these genetic tests at no cost to eligible patients. They achieve this by conducting and funding the program themselves, which makes them the sole operator and custodian of all the data collected. This data, once de-identified (meaning personal information is removed), can be aggregated and shared with third parties or commercial organizations. This approach not only helps patients get the necessary diagnosis and genetic counseling but also allows the company to generate revenue by providing valuable data to research institutions and pharmaceutical companies interested in rare disease drug development.

Probably Genetic serves a niche but critical segment of the healthcare market, focusing on rare disease patients who often face significant challenges in getting timely and accurate diagnoses. By offering a streamlined, patient-friendly process that includes a physician review, genetic counseling, and a comprehensive clinical genetic report, the company aims to fill a significant gap in the current healthcare system.

In summary, Probably Genetic makes money by leveraging the data collected from their genetic tests, which they provide for free to eligible patients. This data is then sold in an aggregated and de-identified form to interested third parties, creating a sustainable revenue stream while also advancing the field of rare disease research.